| [1]胡志兰,何小解,党西强,等.小儿狼疮性肾炎 41例临床与病理分析[J].中华实用儿科临床杂志,2013,28(17):1315-1319.
HU Z L,HE X J,DANG X Q,et al.Clinical and pathological analysis of 41 children with lupus nephritis[J].Journal of Applied Clinical Pediatrics,2013,28(17):1315-1319.
[2]YOSHIDA T,SINHA S,DANDRE F,et al.Myocardin is a key regulator of CArG-dependent transcription of multiple smooth muscle marker genes[J].Circ Res,2003,92(8):856-864.
[3]WEI Y,NAZARI-JAHANTIGH M,NETH P,et al.MicroRNA-126,-145,and -155:a therapeutic triad in atherosclerosis?[J]Arterioscler Thromb Vasc Biol,2013,33(3):449-454.
[4]LOVREN F,PAN Y,QUAN A,et al.MicroRNA-145 targeted therapy reduces atherosclerosis[J].Circulation,2012,126(11 Suppl 1):S81-90.
[5]易著文.儿童常见肾脏疾病诊治循证指南(试行)解读(六):狼疮性肾炎诊断治疗[J].中华儿科杂志,2010,48(9):695-697.
YI Z W.Intensive reading of lupus nephritis:evidence-based guidelines on diagnosis and treatment of common renal diseases in children(Ⅵ) [J].Chinese Journal of Pediatrics,2010,48(9):695-697.
[6]WEENING J J,D’AGATI V D,SCHWARTZ M M,et al.The classification of glomerulonephritis in systemic lupus erythematosus revisited[J].Kidney Int,2004,65(2):521-530.
[7]KATAFUCHI R,KIYOSHI Y,OH Y,et al.Glomerular score as a prognosticator in IgA nephropathy:its usefulness and limitation[J].Clin Nephrol,1998,49(1):1-8.
[8]BANFI G,BERTANI T,BOERI V,et al.Renal vascular lesions as a marker of poor prognosis in patients with lupus nephritis.Gruppo Italiano per lo Studio della Nefrite Lupica(GISNEL)[J].Am J Kidney Dis,1991,18(2):240-248.
[9]ROMAN M J,SHANKER B A,DAVIS A,et al.Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus[J].N Engl J Med,2003,349(25):2399-2406.
[10]PEETTERS M A,CHIZZOLINI C.Cardiovascular risk in autoimmune and inflammatory disorders[J].Rev Med Suisse,2011,7(291):867-871.
[11]MANZI S,MEILAHN E N,RAIRIE J E,et al.Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus:comparison with the Framingham Study[J].Am J Epidemiol,1997,145(5):408-415.
[12]RAJAGOPALAN S,SOMERS E C,BROOK R D,et al.Endothelial cell apoptosis in systemic lupus erythematosus:a common pathway for abnormal vascular function and thrombosis propensity[J].Blood,2004,103(10):3677-3683.
[13]FROSTEGARD J.Systemic lupus erythematosus and cardiovascular disease[J].Lupus,2008,17(5):364-367.
[14]DE LEEUW K,FREIRE B,SMIT A J,et al.Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus[J].Lupus,2006,15(10):675-682.
[15]LIU Z P,WANG Z,YANAGISAWA H,et al.Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin[J].Dev Cell,2005,9(2):261-270.
[16]CORDES K R,SHEEHY N T,WHITE M P,et al.miR-145 and miR-143 regulate smooth muscle cell fate and plasticity[J].Nature,2009,460(7256):705-710. |